1YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Rituximab | 利妥昔单抗 | 174722-31-7 |
| Infliximab | 英夫利昔单抗 | 170277-31-3 |
| Eculizumab | 依库珠单抗 | 219685-50-4 |
| Natalizumab | 那他珠单抗 | 189261-10-7 |
| Amivantamab | 埃万妥单抗 | 171511-58-1 |
| Ivonescimab | 依沃西单抗 | 2428381-53-5 |
| Trastuzumab emtansine | 曲妥珠单抗-美 坦新偶联物 | 1018448-65-1 |
| Dulaglutide | 杜拉鲁肽 | 923950-08-7 |
| Pembrolimumab | 派姆单抗 | 1374853-91-4 |
| Omalizumab | 奥马珠单抗 | 242138-07-4 |
| Tezepelumab | 特折鲁单抗 | 1572943-04-4 |
| Trastuzumab Deruxtecan | 德卢替康-曲妥 珠单抗 | 1826843-81-5 |
| Polatuzumab vedotin | 泊洛妥珠单抗 | 1313206-42-6 |
| Mepolizumab | 美泊丽单抗 | 196078-29-2 |
| Datopotamab deruxtecan | 德达博妥单抗 | 2238831-60-0 |
| Aflibercept | 阿柏西普 | 845771-78-0 |
| Daratumumab | 达雷木单抗 | 945721-28-8 |
| Ocrelizumab | 奥克立珠单抗 | 637334-45-3 |
| Secukinumab | 苏金单抗 | 875356-43-7 |
| Dupliumab | 度匹鲁单抗 | 1190264-60-8 |
| Concizumab | 康赛珠单抗 | 1312299-39-0 |
| Belimumab | 贝利木单抗 | 356547-88-1 |
| Tocilizumab | 托珠单抗 | 375823-41-9 |
| Necitumumab | 耐昔妥珠单抗 | 906805-06-9 |
| Luspatercept | 罗特西普 | 1373715-00-4 |
| Bevacizumab | 贝伐珠单抗 | 216974-75-3 |
| Casirivimab | 卡西里维马布 | 2415933-42-3 |
| Tremelimumab | 曲美木单抗 | 745013-59-6 |
| Pertuzumab | 帕妥珠单抗 | 380610-27-5 |
| Nivolumab | 纳武单抗 | 946414-94-4 |
| Alirocumab | 阿利人单抗 | 1245916-14-6 |
| Sarilumab | 沙利鲁单抗 | 1189541-98-7 |
| Tarlatamab | 塔拉妥单抗 | 2307488-83-9 |
| Vedolizumab | 维多珠单抗 | 943609-66-3 |
| Benralizumab | 贝那利珠单抗 | 1044511-01-4 |
| Penpulimab | 派安普利单抗 | 2350298-92-7 |
| Trastuzumab | 曲妥珠单抗 | 180288-69-1 |
| Imdevimab | 伊姆德维马布 | 2415933-40-1 |
| Ustekinumab | 优特克单抗 | 815610-63-0 |
| Adalimumab | 阿达木单抗 | 331731-18-1 |
| Aducanumab | 阿杜那单抗 | 1384260-65-4 |
| Sacituzumab Govitecan | 戈沙妥珠单抗 | 1491917-83-9 |
| Cemiplimab | 西米普利单抗 | 1801342-60-8 |
| Ipilimumab | 伊匹单抗 | 477202-00-9 |
| Ramucirumab | 雷莫芦单抗 | 947687-13-0 |
| Evolocumab | 依伏库单抗 | 1256937-27-5 |
| Brentuximab | 本妥昔单抗 | 914088-09-8 |
| Telisotuzumab | 特立妥珠单抗 | 1781223-80-0 |
| Panitumumab | 帕尼单抗 | 339177-26-3 |
| Obinutuzumab | 阿托珠单抗 | 949142-50-1 |
| Cetuximab | 西妥昔单抗 | 205923-56-4 |
| Denosumab | 狄诺塞麦/迪诺苏单抗 | 615258-40-7 |
| Durvalumab | 德瓦鲁单抗 | 1428935-60-7 |
| Atezolizumab | 阿特朱单抗 | 1380723-44-3 |
| Lecanemab | 仑卡奈单抗 | 1260393-98-3 |
| Alemtuzumab | 阿伦单抗 | 216503-57-0 |
| Emicizumab | 艾米珠单抗 | 1610943-06-0 |
| Risankizumab | 利生奇珠单抗 | 1612838-76-2 |
| Zenocutuzumab | 泽妥珠单抗 | 1969309-56-5 |
| Donanemab | 多奈单抗 | 1931944-80-7 |
| Serplulimab | 斯鲁利单抗 | 2231029-82-4 |
联系方式
